SS Innovations International Reports Record Q2 Revenue, Signals Continued Momentum for SSi Mantra Robotic Surgery Platform

SS Innovations International (NASDAQ: SSII) has announced record second-quarter revenue of $13.9 million, a 39.4% increase year over year, underscoring the sustained commercial momentum of its SSi Mantra surgical robotic system. The company's first-half revenue reached $25.0 million, up 65.6% from the same period in 2025, reflecting robust demand across its markets.

During the quarter, SS Innovations installed 30 SSi Mantra systems, a 30.4% rise from the prior year, bringing the total installed base to 224 systems across 12 countries. Cumulative surgeries performed with the platform reached 12,272, demonstrating its clinical adoption and operational reliability. The company's telesurgery initiatives are further expanding the clinical profile of SSi Mantra, while system installations remain the primary driver of commercial growth.

The company's financial performance was accompanied by a gross profit increase of 20.0% to $7.1 million in Q2, though gross margin contracted to 50.9% from 59.1% in the year-earlier quarter. For the first half, gross profit rose 77.5% to $12.4 million, with margin improvement compared to the prior year.

Looking ahead, regulatory milestones are expected to be significant catalysts. SS Innovations is targeting FDA clearance for SSi Mantra by the first quarter of 2027 and EU CE marking by the end of 2026. These approvals could open access to the U.S. and European markets, which represent substantial opportunities for the company's robotic surgery platform.

The company's growth trajectory is set against a backdrop of increasing global adoption of robotic-assisted surgery. SSi Mantra's competitive positioning, combined with its expanding installed base and clinical evidence, may enable SS Innovations to capture a larger share of this market. However, the company faces risks including regulatory hurdles, competition, and the need to sustain its growth rate.

As SS Innovations continues to scale, its focus on innovation and market expansion will be critical. The record revenue and system installations signal strong operational execution, but the company must navigate the complexities of entering new regulatory environments and maintaining its technological edge.